Abeona Therapeutics Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 54.19 million compared to USD 39.7 million a year ago. Basic loss per share from continuing operations was USD 2.53 compared to USD 5.53 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 USD | +2.19% | -56.94% | -34.93% |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Apr. 23 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.93% | 89.18M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023